Evidence map›Paper›PMID 42353556›Full record

ArticleCurrent issues in molecular biology2026

Development of a Highly Specific RPA/CRISPR-Cas13a Assay for Detection of

Lucía Ceballos-Romero, Soraya Herrera-Espejo, Daniel Atassi, Pilar Sánchez-Suero, Jerónimo Pachón, José Miguel Cisneros, María Eugenia Pachón-Ibáñez

Abstract read
In one paragraph

Article in Current issues in molecular biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Lucía Ceballos-RomeroCentro de Investigación Biomédica en Red (CIBER) de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, 28029 Madrid, Spain.
Soraya Herrera-EspejoInstitute of Biomedicine of Seville (IBiS), Virgen del Rocio University Hospital/CSIC/University of Seville, 41013 Seville, Spain.ORCID 0000-0001-8019-0905
Daniel AtassiInstitute of Biomedicine of Seville (IBiS), Virgen del Rocio University Hospital/CSIC/University of Seville, 41013 Seville, Spain.
Pilar Sánchez-SueroCentro de Investigación Biomédica en Red (CIBER) de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, 28029 Madrid, Spain.ORCID 0009-0003-8779-560X
Jerónimo PachónInstitute of Biomedicine of Seville (IBiS), Virgen del Rocio University Hospital/CSIC/University of Seville, 41013 Seville, Spain.ORCID 0000-0002-8166-5308
José Miguel CisnerosCentro de Investigación Biomédica en Red (CIBER) de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, 28029 Madrid, Spain.
María Eugenia Pachón-IbáñezCentro de Investigación Biomédica en Red (CIBER) de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, 28029 Madrid, Spain.ORCID 0000-0001-7969-8162

Funding

Andalusian Health Service RC1-0006-2023Centro de Investigación Biomédica en Red CB21/13/00006Instituto de Salud Carlos III FI21/00280Instituto de Salud Carlos III PI20/01044
6 · The paper itself

Abstract

Rapid detection of

Indexed as

high-specificitymultidrug-resistance detectionPseudomonas aeruginosarapid diagnosisRPA/CRISPR-Cas13a

Identifiers

PMID42353556
PMCPMC13297620

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.